Geniol (Acetaminophen)

Quick links to important sections

Geniol (Acetaminophen)

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Geniol (Acetaminophen)

For a quick reference on the drug's essential properties:

Property Description
Active Ingredient Acetaminophen (Paracetamol)
Pharmacological Class Analgesic (Pain Reliever) and Antipyretic (Fever Reducer)
Geniol Form Immediate Release Tablets (500 mg)
Manufacturer XenoFarma
Origin Synthetically Produced
Common Use Symptomatic relief of mild to moderate pain and fever

What Type of Medicine is Geniol (Acetaminophen)?

Geniol is an over-the-counter (OTC) medication whose single active ingredient is Acetaminophen (INN). This compound is formally categorized as both an analgesic and an antipyretic, a classification that is clinically recognized worldwide and supported by pharmacological studies.

Acetaminophen is highly accepted because its mechanism is distinct from Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); it primarily targets the central nervous system without causing significant anti-inflammatory effects peripherally. This makes Acetaminophen a key tool for managing general discomfort like headaches and fever. The World Health Organization (WHO) has listed Acetaminophen on its List of Essential Medicines, underscoring its therapeutic importance in basic healthcare.


Composition and Origin: The Makeup of Geniol

The active substance in Geniol is a synthetically produced chemical compound and is not derived from natural or herbal sources. Geniol is specifically manufactured by XenoFarma and is available as Immediate Release Tablets (500 mg), designed for convenient oral administration.

While Acetaminophen is the core ingredient across numerous OTC products, Geniol focuses on delivering the pure, single ingredient. This controlled formulation is intended to give users a reliable and singular source of pain and fever relief. As a single-ingredient drug, this formulation allows consumers to carefully manage their intake, which is critical for safe use.

Regulatory References

  1. Acetaminophen - StatPearls - NCBI Bookshelf
  2. WHO Model Lists of Essential Medicines
  3. Paracetamol (acetaminophen) on WHO EML

What side effects are possible with Geniol (Acetaminophen)?

Possible Side Effects and Safety Information

The safety profile of Geniol, which contains the active ingredient Acetaminophen (Paracetamol), is described in regulatory documents by focusing on high-level constraints and the potential for serious adverse reactions, with many common effects being classified as rare or not known in frequency for oral formulations.


Serious Safety Constraints and Organ System Effects

The most critical documented safety concern is the risk of Severe Hepatotoxicity, which can lead to Acute Liver Failure. This risk is heightened when the total recommended daily dosage of acetaminophen is exceeded or when multiple acetaminophen-containing products are used concurrently. Adverse reactions are grouped by System-Organ Class, with primary focus on Hepatobiliary Disorders.


Hypersensitivity and Systemic Reactions

Acetaminophen has been associated with the development of Serious Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which are classified as very rare. Reactions affecting the Immune System, including general hypersensitivity and anaphylactic shock, are also documented, often with a frequency categorized as not known from available data.

Classification Examples of Reactions Affected Systems
Very Rare Serious Skin Reactions (SJS, TEN) Skin and Subcutaneous Tissue
Rare/Not Known Blood Dyscrasias, Anaphylaxis Blood, Immune System

Population-Specific Safety Considerations

Official labeling defines specific safety constraints for particular patient populations. The medicine is contraindicated in patients with severe hepatic impairment or active liver disease. Caution is also advised in patients with severe renal impairment or those with risk factors for hepatotoxicity, such as chronic alcohol use.

Overdose and Emergency Response

Documented Overdose Manifestations

Acetaminophen (Geniol) overdose is officially documented as carrying a severe risk of acute liver failure, which can be life-threatening and may require liver transplantation. The serious outcomes listed in regulatory documents include hepatic necrosis and secondary acute kidney injury. Initial clinical manifestations may be non-specific, often including nausea, vomiting, sweating, or abdominal pain. The regulatory profile notes that a serious overdose can also be asymptomatic in the early phase, emphasizing that the absence of initial symptoms does not preclude severe delayed toxicity.

Emergency Actions and Management

Immediate medical attention is required for any suspected overdose, regardless of whether symptoms are present, as mandated by official emergency response statements. Patients must contact a Poison Control Center or seek urgent medical evaluation without delay. Management relies on the administration of N-acetylcysteine, the specific antidote, which is most effective when given quickly, typically within hours of ingestion. Regulatory guidance mandates the measurement of serum acetaminophen concentration to assess toxicity risk and determine treatment protocols. Hospital monitoring is required, and the evaluation includes regular monitoring of hepatic and renal function tests. Population-specific considerations note an increased risk of severe hepatotoxicity in individuals with pre-existing liver disease or those who consume chronic alcohol.

Therapeutic Uses of Geniol (Acetaminophen)

What Geniol (Acetaminophen) Treats: Main Uses and Benefits

Geniol is commonly used to help with symptoms related to physical discomfort and systemic imbalance, supporting symptomatic relief as an analgesic and an antipyretic. It is applied in clinical settings that involve acute or unstable symptom patterns. This includes the management of symptoms such as pain and fever.

The medication is commonly used to help with symptoms that manifest as pain, such as headaches, toothaches, muscular aches, and menstrual cramps. It is also commonly used when symptoms become more noticeable due to an elevated core body temperature, such as during the common cold or flu. This application helps address symptom clusters that may become intense or disruptive.

“It is used in settings where short-term symptom stabilization is important, helping address symptoms that interfere with daily comfort.”

Quick Fact: Relief for Episodic Discomfort

Geniol is frequently applied in conditions involving episodic or fluctuating manifestations, such as post-vaccination soreness or acute, temporary pain. It provides support that helps ease the overall symptom burden and assists with maintaining functional stability during these acute episodes.

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Geniol (Acetaminophen)?

The eligibility for Geniol (Acetaminophen) use is defined by official regulatory bodies, focusing on patient health status and age.


Eligibility Scope

Category Official Regulatory Status
Populations for whom use is allowed General adult population and adolescents. Children above specific age/weight thresholds may use appropriate low-strength formulations.
Populations for whom use is not recommended Children under 2 years of age for over-the-counter products, unless directed by a healthcare professional.
Populations for whom use is contraindicated Patients with known hypersensitivity to Acetaminophen or any excipient. Individuals with severe hepatic impairment or severe active liver disease.
Age-related eligibility rules The 500 mg tablet strength is generally not recommended for young children due to dosage.
Condition-specific eligibility rules Use requires caution and a pre-use consultation for patients with non-severe liver disease, severe kidney disease, or chronic alcoholism.
Pregnancy and lactation eligibility status Permitted during pregnancy if clinically needed, using the lowest effective dose for the shortest duration. Permitted during lactation at therapeutic doses.

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording
Eligibility severity classification Contraindicated: Severe hepatic impairment, known hypersensitivity. Ask a Doctor Before Use: Liver disease, chronic alcohol use.
Eligibility-context constraints Constraints are defined by organ function status (hepatic, renal) and the mandate against using the medicine in combination with any other Acetaminophen product.

Official Eligibility Statements:

  • Contraindicated for patients with a known hypersensitivity to Acetaminophen.
  • Contraindicated for individuals diagnosed with severe hepatic impairment or severe active liver disease.
  • Use during pregnancy is permitted if clinically needed, prioritizing the lowest effective dose for the shortest possible duration.

This structure defines eligibility by establishing non-negotiable contraindications (severe liver disease, allergy) and outlining conditions for conditional eligibility based on age limits and pre-existing organ function status.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Geniol (Acetaminophen) establishes specific restrictions and documented interaction profiles based on pharmacokinetic and pharmacodynamic mechanisms.

Prohibited Co-administration

The primary restriction is the strict contraindication against combining Geniol with any other medicinal product containing acetaminophen or paracetamol. This rule is documented to prevent inadvertent overdose and the associated hazard of severe liver damage.

Pharmacokinetic Alterations

The drug’s clearance and absorption are officially affected by several substances. Probenecid reduces Acetaminophen's clearance by inhibiting conjugation, thereby increasing plasma exposure. Absorption speed is increased by Metoclopramide or Domperidone, while Colestyramine reduces the rate of absorption. Further, hepatic enzyme inducers, such as Rifampicin or Phenytoin, increase the formation of the toxic metabolite, raising the documented risk of hepatotoxicity.

Pharmacodynamic and Substance Risks

A clinically significant pharmacodynamic interaction is noted with Warfarin and other oral anticoagulants, where prolonged regular daily use enhances the anticoagulant effect, increasing bleeding risk. The label also documents a specific association between co-administration with Flucloxacillin and a risk of high anion gap metabolic acidosis. For non-medicinal substances, severe liver damage is documented when three or more alcoholic drinks are consumed daily during use. Patients with hepatic impairment or chronic alcohol use are noted to have a greater hazard of toxicity.

Mechanism of Action

How Geniol (Acetaminophen) Works


Central Inhibition of Prostaglandin Synthesis

This core mechanism involves Geniol's ability to selectively inhibit cyclooxygenase (COX) enzymes, particularly in the central nervous system (CNS). This targeted action reduces the synthesis of prostaglandins, which are key mediators that sensitize pain pathways and elevate the body's temperature set point, thus modulating the hypothalamic set-point for temperature regulation and reducing nociceptor sensitization.


Modulation of Serotonergic Pain Control Pathways

Geniol engages mechanisms that regulate the body's intrinsic pain control systems, specifically by affecting descending serotonergic pathways in the spinal cord. This modulates the transmission of pain signals by enhancing inhibitory effects, influencing descending inhibitory pathways and altering signal transmission in nociceptive pathways.


Indirect Endocannabinoid System Engagement

A secondary mechanistic domain involves the regulation of the endocannabinoid system (ECS) through a metabolite (AM404). This action may enhance the activity of anandamide (AEA) by limiting its breakdown or reuptake, which then leads to an indirect CB1 receptor-mediated effect. This metabolic pathway influences the persistence of anandamide (AEA), thereby indirectly engaging CB1 receptor activity.

Dosage and Administration Information

How to Use Geniol (Acetaminophen)

This section describes the label-based administration principles for Acetaminophen, the active ingredient in Geniol immediate-release tablets.


Administration and Dosing Principles

The most common route of administration for the Geniol tablet is oral intake, where the medication is swallowed whole. Instructions specify that the medicine may be taken with or without food.

The standard adult single dose for immediate-release forms ranges from 500 mg to 1000 mg. The administration frequency is designated as As-Needed (PRN), with a minimum interval of 4 to 6 hours required between doses to allow the body to clear the medicine.

Maximum Intake and Duration

A critical component of use is adherence to the maximum total daily intake. The maximum cumulative dose from all sources containing Acetaminophen (including combination products) must not exceed 4000 mg in a 24-hour period.

For self-medication, the duration of use is constrained. The drug is intended for intermittent, short-term use, and should not be taken for more than 10 consecutive days for pain relief, or 3 days for fever, without medical supervision. If a dose is missed during a scheduled regimen, the instructions are to skip the missed dose and resume the regular schedule, without doubling the subsequent dose.

Population-Specific Use

Labeling requires adjustments for specific populations. Dosing for pediatric patients is based on body weight (typically 10 to 15 mg/kg per dose). Furthermore, patients with severe renal or hepatic impairment are typically instructed to use a reduced maximum daily dose or to extend the interval between doses.

Recent Clinical Evidence

Geniol (Acetaminophen): Recent Clinical Evidence

Acetaminophen, the active ingredient in Geniol, is a widely used non-opioid analgesic and antipyretic agent. Recent clinical research focuses on its role in multimodal pain management, long-term use, and safety profile.


Acute Pain Management Studies

Acetaminophen is typically studied for its effect on mild to moderate acute pain and fever. In the context of moderate to severe pain, research has often explored its use as an adjunctive agent alongside stronger analgesics.

  • Combination Therapy: Studies, particularly those involving postoperative and dental pain, report that combining acetaminophen with a non-steroidal anti-inflammatory drug (NSAID), such as ibuprofen, may provide improved pain relief compared to either agent used alone. This combination approach may also reduce the need for rescue opioid medication in some acute settings.

  • Intravenous (IV) Use: Research comparing intravenous acetaminophen to IV opioids for acute pain in emergency settings has generally reported similar or modestly lower levels of pain relief, often with a lower risk of certain adverse events.


Long-term Use and Safety Profile

While acetaminophen is generally considered safe when used within recommended dosage limits, prolonged daily use for chronic conditions has been a subject of increased scrutiny.

  • Efficacy in Chronic Pain: Several systematic reviews suggest that the efficacy of acetaminophen for some chronic conditions, such as long-term management of osteoarthritis (OA) pain, may be limited or minimal.
  • Safety Concerns: Observational studies examining prolonged, high-frequency use of acetaminophen have reported associations with an increased risk of adverse outcomes, including certain gastrointestinal, renal, and cardiovascular effects, particularly in older adults (age 65 and over). These findings emphasize the importance of using the lowest effective dose for the shortest necessary duration.
Research Focus Key Finding Status
Acute Combination Therapy (with NSAIDs) Reported potential for increased pain relief compared to monotherapy. Established
Long-Term Chronic Pain Efficacy Evidence suggests limited or minimal clinical benefit in conditions like OA. Under Reassessment
Prolonged High-Frequency Use Safety Observational data reported associations with certain risks (e.g., renal/CV effects). Scrutinized

Key Studies & References

  1. NICE Guideline NG149: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain

Frequently Asked Questions (FAQ)

Common questions about Geniol (Acetaminophen) (FAQ)

Q: Does this medicine make you sleepy?

A: Official product information indicates that this medicine is not labeled as a sleep aid. However, the regulatory label warns that some effects, such as nervousness, dizziness, or sleeplessness, can occur while using this product. If unwanted effects occur, the official label suggests consulting a healthcare professional.

Q: Can I take this if I have high blood pressure?

A: Regulatory documents advise that individuals who have heart disease or high blood pressure should consult with a doctor before using this product. This caution is standard because one of the ingredients can affect circulation. The regulatory information indicates that a doctor is best suited to evaluate the use of this product based on your individual health profile.

Q: Is this safe for children 6 years old?

A: According to the official Directions for Use, children under 12 years old should not use this product unless directed by a doctor. The product labeling specifies that consultation with a healthcare provider is advised before administration to children in this age group.

Q: Can I take this for more than 7 days?

A: The official product information advises users to stop taking the medicine and consult a doctor if pain or nasal congestion gets worse or lasts for more than 7 days. The regulatory labeling does not endorse long-term use without professional oversight.

Q: Should I avoid alcohol while taking this?

A: The regulatory warnings section advises consulting a doctor or pharmacist before using this medicine if you regularly consume three or more alcoholic drinks per day. This caution relates to the potential combined effects of the acetaminophen component and alcohol.

How should Geniol (Acetaminophen) be stored and disposed of?

Official Storage and Disposal Instructions

Geniol (Acetaminophen) must be stored in accordance with regulatory conditions to maintain stability and ensure safety.

Storage Requirement Official Condition
Temperature Store at controlled room temperature, typically 20^circ to 25 C (68^circ to 77 F).
Protection Keep the container tightly closed and protect from excess moisture, heat, and direct light. Do not freeze.
Child Safety Must be stored out of the sight and reach of children; securely lock the safety cap after each use.

For disposal, the product must not be flushed down a toilet or sink. The preferred method for unused or expired medicine is an official drug take-back program. If one is unavailable, the medicine should be removed from its original container, mixed with an unappealing substance (like cat litter), placed in a sealed bag, and discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Geniol (Acetaminophen) found in:

A-Z Index: